Work

Abstract A044: LP-184, a Novel Acylfulvene, Sensitizes Immuno-refractory Triple-Negative Breast Cancers (TNBCs) To Anti-PD1 Therapy by Affecting the Tumor Microenvironment

Year: 2025

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.io2025-a044

Authors: Yong Du, Aditya Kulkarni, Jianli Zhou, Hui Dai, Kishor Bhatia, Shiaw-Yih Lin

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407866819

Cites:

Cited by:

Related to: 10